Oral contraceptives and bone mineral density in white and black women in CARDIA

Osteoporosis International

Volumn 13, Issue 11, 2002, Pages 893-900

  Cobb, K L ^a   Kelsey, J L ^a   Sidney, S ^b   Ettinger, B ^b   Lewis, C E ^c  

^a STANFORD UNIVERSITY   (United States)

^b DIVISION OF RESEARCH   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Bone mineral density; Estrogen; Ethinyl estradiol; Oral contraceptives; Osteoporosis

Indexed keywords

ETHINYLESTRADIOL; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE MINERAL; CAUCASIAN; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG USE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIP; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; QUESTIONNAIRE; SPINE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ANTHROPOMETRY; BONE DENSITY; COHORT STUDIES; CONTRACEPTIVES, ORAL, HORMONAL; CROSS-SECTIONAL STUDIES; ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FEMUR NECK; HUMANS; ODDS RATIO; PREMENOPAUSE; SPINE;

EID: 0036851746     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001980200123     Document Type: Article

References (43)

1. Rizzoli R, Bonjour JP. Hormones and bones. Lancet 1997;349 (Suppl 1):s120-6.
2. Goldsmith NF, Johnston JO. Bone mineral effects of oral contraceptives, pregnancy and lactation. J Bone Joint Surg Am 1975;57:657-68.
3. Lindsay R, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 1986;9:375-8.
4. Pasco JA, Kotowicz MA, Henry MJ, et al. Oral contraceptives and bone mineral density: A population-based study. Am J Obstet Gynecol 2000;182:265-9.
5. Petitti DB, Piaggio G, Mehta S, et al. Steroid hormone contraception and bone mineral density: A cross-sectional study in an international population. Obstet Gynecol 2000;95:736-44.
6. Stevenson JC, Less B, Devenport M, et al. Determinants of bone density in normal women: Risk factors for future osteoporosis? BMJ 1989;298:924-8.
7. Kritz-Silverstein D, Barrett-Connor E. Bone mineral density in postmenopausal women as determined by prior oral contracpetive use. Am J Public Health 1993;83:100-2.
8. Masaryk P, Lunt M, Benevolenskaya L, et al. Effects of menstrual history and use of medications on bone mineral density: The EVOS study. Calcif Tissue Int 1998;63:271-6.
9. Enzelberger H, Metka M, Heytmanek G. Influence of oral contraceptive use on bone density in climacteric women. Maturitas 1988;9:375-8.
10. Kleerekoper M, Brienza RS, Schultz LR, Johnson CC. Oral contraceptive use may protect against low bone mass. Arch Intern Med 1991; 151:1971-6.
11. Johnell O, Nilsson BE. Life-style and bone mineral mass in perimenopause women. Calcif Tissue Int 1984;36:354-6.
12. Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 1988;159:318-22.
13. Hall ML, Heavens J, Cullum ID, Ell PJ. The range of bone density in normal British women. Br J Radiol 1990;63:266-9.
14. Lloyd T, Buchanan JR, Ursino GR, et al. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol 1989;160:402-4.
15. Sowers MF, Wallace RB, Lemke JH. Correlates of forearm bone mass among women during maximal bone mineralization. Prev Med 1985;14:585-96.
16. Fortney JA, Feldblum RV, Talmage RV, et al. Bone mineral density and history of oral contraceptive use. J Reprod Med 1994;39:105-9.
17. Mazess RB, Barden HS. Bone density in premenopausal women: Effects of age, dietary intake, physical activity, smoking, and birth control pills. Am J Clin Nutr 1991;53:132-42.
18. Murphy S, Khaw KT, Compston JE. Lack of relationship between hip and spine bone mineral density and oral contraceptive use. Eur J Clin Invest 1993;23:108-11.
19. Friedman GD, Cutter GR, Donahue RP, et al. CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988;41:1105-16.
20. Wagenknecht LE, Perkins LL, Cutter GR. Cigarette smoking behavior is strongly related to educational status: The CARDIA study. Prev Med 1990;19:158-69.
21. Dyer AR, Cutter GR, Liu K, et al. Alcohol intake and blood pressure in young adults: The CARDIA study. J Clin Epidemiol 1990;43:1-13.
22. Jacobs DR, Hahn LP, Kaskell WL, et al. Validity and reliability of a short physical activity history: CARDIA and the Minneapolis Heart Health Program. J Cardiopulmon Rehab 1989;9:448-59.
23. McDonald A, Van Horn L, Slattery M, et al. The CARDIA dietary history: Development and implementation. J Am Diet Assoc 1991;91: 1104-12.
24. Heaney RP. A unified concept of osteoporosis. Am J Med 1965; 39:377-80.
25. Cosman F, Shen V, Fang X, et al. Estrogen protection against bone remodeling effects of parathyroid hormone infusion. Ann Intern Med 1993;118:337-43.
26. Cosman, F, Morgan DC, Nieves JW, et al. Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 1997;12:958-66.
27. Bikle DD, Ettinger B, Sidney S, et al. Differences in calcium metabolism between black and white men and women. Miner Electrolyte Metab 1990;25:178-84.
28. Harris SS, Wood MJ, Dawson-Hughes B. Bone mineral density of the total body and forearm in premenopausal black and white women. Bone 1995;4(Suppl):S311-5.
29. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 1987;106:40-5.
30. Recker RR, Davies KM, Dowd RM, Heaney RP. The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: A randomized, controlled trial. Ann Intern Med 1999;130:897-904.
31. Genant HK, Lucas J, Weiss S, et al. Low-dose esterified estrogen therapy: Effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group. Arch Intern Med 1997;157:2609-15.
32. Vedi S, Purdie DW, Ballard P, et al. Bone remodeling and structure in postmenopausal women treated with long-term, highdose oestrogen therapy. Osteoporos Int 1999;10:52-8.
33. Wahab M, Ballard P, Purdie DW, et al. The long-term effects of oestradiol implantation on bone mineral density in postmenopausal women who have undergone hysterectomy and bilateral oophorectomy. Br J Obstet Gynaecol 1997; 104:728-31.
34. Wagenknecht LE, Cutter GR, Haley NJ, et al. Racial differences in serum cotinine levels among smokers in the CARDIA study. Am J Public Health 1990;80:1053-6.
35. Ganry O, Baudoin C, Fardelione, P. Effect of alcohol intake on bone mineral density in elderly women: The EPIDOS Study. Am J Epidemiol 2000;151:773-80.
36. Holbrook TL and Barrett-Connor E. A prospective study of alcohol consumption and bone mineral density. BMJ 1993;306:1506-9.
37. Hopper JL, Seeman E. The bone density of female twins discordant for tobacco use. N Engl J Med 1994;330:387-92.
38. Shagril AA. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: A three-year prospective study. Int J Fertil 1985;30:15-28.
39. Volpe A, Amram A, Cagnacci A, Battaglia C. Biochemical aspects of hormonal contraception: Effects on bone metabolism. Eur J Contracept Reprod Health Care 1997;2:123-6.
40. Gambacciani M, Spinetti A, Cappagli B, et al. Hormone replacement therapy in perimenopausal women with a low dose oral contraceptive preparation: Effects on bone mineral density and metabolism. Maturitas 1994;19:125-31.
41. Gambacciani M, Spinetti A, Taponeco F, et al. Longitudinal evaluation of perimenopausal vertebral loss: Effects of a low dose oral contraceptive preparation on bone mineral density metabolism. Obstet Gynecol 1994;83:392-6.
42. Mais V, Fruzetti F, Ajossa S. Bone metabolism in young women taking a monophasic pill containing 20 mcg ethinylestradiol: A prospective study. Contraception 1993;48:445-52.
43. Cromer B, Blair JM, Mahan JD, et al. A prospective comparison of bone-density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996; 129:671-6.